Cyclacel Pharmaceuticals, Inc. (CYCC) Social Stream
CYCLACEL PHARMACEUTICALS INC (CYCC) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CYCLACEL PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 3 | $24 | $17 | $21 | $2.78 | 655.4% |
| 2022-07-18 | 4 | $24 | $17 | $20 | $2.78 | 619.42% |
| 2022-10-26 | 4 | $22.001 | $16 | $18 | $2.78 | 547.48% |
| 2022-11-10 | 4 | $22 | $16 | $18 | $2.78 | 547.48% |
| 2023-03-07 | 4 | $22 | $10 | $16.25 | $2.78 | 484.53% |
| 2023-05-24 | 4 | $19 | $8 | $13.5 | $2.78 | 385.61% |
| 2023-09-28 | 4 | $16 | $8 | $12.25 | $2.78 | 340.65% |
| 2023-11-14 | 3 | $239.88 | $164.917 | $204.897 | $2.78 | 7270.4% |
| 2023-12-19 | 3 | $164.917 | $21 | $92.958 | $2.78 | 3243.81% |
The Trend in the Analyst Price Target
Over the past 29 months, CYCC's average price target has gone up $72.71.
Over the past 41 weeks, CYCC's average upside potential has been 6,907.83%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-07 | 4 | 22.000 | 10 | 16.250 | 0.729 | 2129.08% |
| 2023-05-11 | 4 | 19.000 | 8 | 13.500 | 0.557 | 2323.7% |
| 2023-09-28 | 4 | 16.000 | 8 | 12.250 | 0.344 | 3461.05% |
| 2023-09-28 | 3 | 16.000 | 8 | 12.250 | 0.344 | 3461.05% |
| 2023-12-19 | 3 | 164.917 | 21 | 92.958 | 3.370 | 2658.4% |
CYCC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 2 | 0 | 1 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 16 months, CYCC's average broker recommendation rating worsened by 0.67.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CYCC as an investment opportunity.
- In terms of how CYCLACEL PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1043.03% of that group.
- CYCLACEL PHARMACEUTICALS INC's number of analysts covering the stock is greater than 122.71% of all US stocks.
- CYCC has a higher average analyst price target than 425.46% of Healthcare stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, CYCLACEL PHARMACEUTICALS INC's variance in analysts' estimates is lower than -315.7% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CYCLACEL PHARMACEUTICALS INC are SONN, CPHI, and PRPH.
View All Top Stocks by Price Target
Is CYCC a Buy, Hold or Sell? See the POWR Ratings now!